S100A9 and lung carcinoma: In addition, studies using a mouse lung cancer model have found that the S100A8/S100A9–EMMPRIN–Vegfa axis promotes tumor angiogenesis and progression, which is associated with the prognosis of lung cancer patients (Nguyen et al., 2021).